# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-26-002644
Filing Date
2026-04-03
Accepted
2026-04-03 11:58:23
Documents
86
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K FOR DEC 2025 | sunshine_i10k-123125.htm iXBRL | 10-K | 1079582
2 | CONSENT OF BUSH & ASSOCIATES CPA LLC | sunshine_ex2301.htm | EX-23.1 | 4295
3 | CONSENT OF M&K CPAS, PLLC | sunshine_ex2302.htm | EX-23.2 | 3862
4 | CERTIFICATION | sunshine_ex3101.htm | EX-31.1 | 10483
5 | CERTIFICATION | sunshine_ex3102.htm | EX-31.2 | 10480
6 | CERTIFICATION | sunshine_ex3201.htm | EX-32.1 | 5129
12 | GRAPHIC | image_001.jpg | GRAPHIC | 6215
13 | GRAPHIC | image_003.jpg | GRAPHIC | 14603
14 | GRAPHIC | bushheader.jpg | GRAPHIC | 11570
15 | GRAPHIC | image_002.jpg | GRAPHIC | 7467
| Complete submission text file | 0001683168-26-002644.txt |  | 5623932

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | sbfm-20251231.xsd | EX-101.SCH | 43956
8 | XBRL CALCULATION FILE | sbfm-20251231_cal.xml | EX-101.CAL | 66533
9 | XBRL DEFINITION FILE | sbfm-20251231_def.xml | EX-101.DEF | 138037
10 | XBRL LABEL FILE | sbfm-20251231_lab.xml | EX-101.LAB | 363655
11 | XBRL PRESENTATION FILE | sbfm-20251231_pre.xml | EX-101.PRE | 303584
90 | EXTRACTED XBRL INSTANCE DOCUMENT | sunshine_i10k-123125_htm.xml | XML | 723347

Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-330-0684
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41282 | Film No.: 26837255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)